Selank peptide: sequence, CAS number and chemical form

Selank TKPRPGP identity, its sequence relationship to tuftsin, CAS number, formula and molecular weight, with separate checks for salt and batch documents.

Substantially revised on 3 October 2026 to focus on molecular identity, naming, chemistry, testing and batch documentation.

Selank is the seven-residue peptide TKPRPGP. Its sequence consists of the four-residue tuftsin sequence TKPR followed by Pro–Gly–Pro. The peptide chain and a stated salt form are separate parts of its chemical description.

Selank identity at a glance

PubChem identifies Selank as Thr–Lys–Pro–Arg–Pro–Gly–Pro. The supplied report prints the same TKPRPGP sequence. The database formula below is the peptide structure without added acetate components.PubChem — Selank, CID 11765600 (opens in a new tab)Supplied Selank 10 mg report — lot SEL-39-QBY (opens in a new tab)

Selank molecular reference
FieldReference value
NameSelank
SequenceThr–Lys–Pro–Arg–Pro–Gly–Pro (TKPRPGP)
CAS number129954-34-3
Molecular formulaC33H57N11O9
Molecular weight751.9 g/mol, PubChem reference structure
PubChem — Selank, CID 11765600 (opens in a new tab)

Tuftsin, the PGP extension and salt form

The sequence relationship
MaterialShared segmentAdditional segment
TuftsinTKPRNone
SelankTKPRPGP
Semenova et al. (2009) (opens in a new tab)Volkova et al. (2016) (opens in a new tab)

This alignment separates the four-residue starting sequence from the seven-residue peptide. Keep the exact chain in an analytical specification; a reference labelled tuftsin specifies a different sequence from Selank.Semenova et al. (2009) (opens in a new tab)PubChem — Selank, CID 11765600 (opens in a new tab)

Volkova and colleagues describe their Selank material as a diacetate salt. That is a description of the material in that source. The supplied Novum report identifies TKPRPGP and a freeze-dried form but does not print a complete salt composition.Volkova et al. (2016) (opens in a new tab)Supplied Selank 10 mg report — lot SEL-39-QBY (opens in a new tab)

Check the name, sequence and analytical target

For the supplied report, retain the Selank name, TKPRPGP sequence, lot SEL-39-QBY and LC-HRMS identity wording together. Read the chromatographic percentage, measured peptide content, water and residual TFA as their own fields. The report assesses these separately.Supplied Selank 10 mg report — lot SEL-39-QBY (opens in a new tab)

Product and certificate documents

Sources and further detail

  1. PubChem — Selank, CID 11765600 (opens in a new tab)

    Existing dossier record rechecked for sequence, CAS, formula and molecular weight.

  2. Volkova et al. (2016) (opens in a new tab)

    Material description and TKPR–PGP identity only.

  3. Semenova et al. (2009) (opens in a new tab)

    Existing comparison dossier: TKPR and TKPRPGP sequence alignment only.

  4. Supplied Selank 10 mg report — lot SEL-39-QBY (opens in a new tab)

    Supplied report: identity wording and analytical fields. Results concern the named sample and lot; this is document transcription, not independent authentication.

Identity sources and supplied documents checked for this revision on 3 October 2026. Report transcription is separate from independent authentication. This article has not undergone independent scientific peer review.

Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only